Branched-chain amino acids in liver disease: New aspects of long known phenomena

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 1, 2011, Pages 61-66

  Plauth, Mathias ^a   Schütz, Tatjana ^b  

^a DESSAU MEDICAL CENTER   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Branched chain amino acid antagonism; Isoleucine; Leucine; Liver cirrhosis; Valine

Indexed keywords

BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE;

ACUTE LIVER FAILURE; ALBUMIN BLOOD LEVEL; ARTICLE; CARBOHYDRATE METABOLISM; DISEASE SEVERITY; DRUG EFFECT; ENERGY METABOLISM; HEPATIC ENCEPHALOPATHY; HUMAN; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; NITROGEN METABOLISM; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROTEIN SYNTHESIS; UREMIA;

AMINO ACIDS, BRANCHED-CHAIN; AZOTEMIA; BLOOD PROTEINS; DIETARY SUPPLEMENTS; ENERGY METABOLISM; HEMOGLOBINS; HEPATIC ENCEPHALOPATHY; HUMANS; ISOLEUCINE; LEUCINE; LIVER CIRRHOSIS; NITROGEN; POSTOPERATIVE COMPLICATIONS; PROTEIN BIOSYNTHESIS;

EID: 79851508534     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283413726     Document Type: Article

References (36)

1. Khanna S, Gopalan S. Role of branched-chain amino acids in liver disease: the evidence for and against. Curr Opin Clin Nutr Metab Care 2007; 10:297-303. (Pubitemid 46596705)
2. Montanari A, Simoni I, Vallisa D, et al. Free amino acids in plasma and skeletal muscle of patients with liver cirrhosis. Hepatology 1988; 8:1034-1039.
3. Plauth M, Egberts E-H, Abele R, et al. Characteristic pattern of free amino acids in plasma and skeletal muscle in stable hepatic cirrhosis. Hepato-Gastroenterol 1990; 37:135-139. (Pubitemid 20092224)
4. Peng S, Plank LD, McCall JL, et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007; 85:1257-1266. (Pubitemid 46740467)
5. Holecek M. Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 2010; 26:482-490.
6. Plauth M, Cabré E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006; 25:285-294. (Pubitemid 43811683)
7. Chadalavada R, Sappati Biyyani RS, Maxwell J, Mullen K. Nutrition in hepatic encephalopathy. Nutr Clin Pract 2010; 25:257-264.
8. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr 2006; 136 (1 Suppl):295S-298S. (Pubitemid 43156528)
9. Koivusalo AM, Teikari T, Höckerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008; 23:387-398.
10. Kakazu E, Kanno N, Ueno Y, Shimosegawa T. Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol 2007; 179:7137-7146.
11. Kakazu E, Ueno Y, Kondo Y, et al. Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology 2009; 50:1936-1945.
12. Nakamura I, Ochiai K, Imai Y, et al. Restoration of innate host defense responses by oral supplementation ofbranched-chain amino acids in decom-pensated cirrhotic patients. Hepatol Res 2007; 37:1062-1067. (Pubitemid 350028333)
13. Schulte-Frohlinde E, Wagenpfeil S, Willis J, et al. Role of meal carbohydrate contentfor the imbalance ofplasma amino acids in patients with liver cirrhosis. J Gastroenterol Hepatol 2007; 22:1241-1248. (Pubitemid 47222647)
14. Kawaguchi T, Nagao Y, Matsuoka H, et al. Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease. Int J Mol Med 2008; 22:105-112.
15. Urata Y, Okita K, Korenaga K, et al. The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis. Hepatol Res 2007; 37:510-516. (Pubitemid 46864246)
16. Aoyama K, Tsuchiya M, Mori K, et al. Effect of a late evening snack on out patients with liver cirrhosis. Hepatol Res 2007; 37:608-614. (Pubitemid 47009246)
17. Korenaga K, Korenaga M, Uchida K, et al. Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis. Hepatol Res 2008; 38:1087-1097.
18. Higuchi N, Kato M, Miyazaki M, et al. Potential role of branched-chain aminoacids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver. J Cell Biochem 2010. [Epub ahead of print]
19. Nakaya Y, Okita K, Suzuki K, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23:113-120. (Pubitemid 46096726)
20. Plank LD, Gane EJ, Peng S, et al. Nocturnal nutritional supplementation improves total bodyprotein status of patients with liver cirrhosis: arandomized 12-month trial. Hepatology 2008; 48:557-566.
21. Kawamura E, Habu D, Morikawa H, et al. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for preliver transplant status. Liver Transpl 2009; 15:790-797.
22. Muto Y, Sato S, Watanabe A, et al. Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3:705-713. (Pubitemid 40984733)
23. Habu D, Nishiguchi S, Nakatani S, et al. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis. Hepato-gastroenterology 2009; 56:1719-1723.
24. van Berlo CLH, van de Bogaard EJM, van der Heijden MH, et al. Is increased ammonia liberation after bleeding in the digestive tract the consequence of complete absence of isoleucine in hemoglobin? A study in pigs. Hepatology 1989; 10:315-323. (Pubitemid 19214956)
25. Olde Damink SW, Dejong CH, Deutz NE, et al. Upper gastrointestinal bleeding: an ammoniagenic and catabolic event due to the total absence of isoleucine in the haemoglobin molecule. Med Hypotheses 1999; 52:515-519. (Pubitemid 29322569)
26. Olde Damink SW, Jalan R, Deutz NE, et al. Isoleucine infusion during 'simulated' upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients. Hepatology 2007; 45:560-568. (Pubitemid 46450608)
27. Olde Damink SW, Jalan R, Deutz NE, et al. Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis. J Hepatol 2008; 49:726-731.
28. Brosnan JT, Brosnan ME. Branched-chain amino acids: enzyme and substrate regulation. J Nutr 2006; 136 (1 Suppl):207S-211S. (Pubitemid 43156510)
29. Malaguarnera M, Risino C, Cammalleri L, et al. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study. Eur J Gastroenterol Hepatol 2009; 21:762-770.
30. Plauth M, Cabré E, Campillo B, et al. ESPEN guidelines in parenteral nutrition: hepatology. Clin Nutr 2009; 28:436-444.
31. Hayashi M, Ikezawa K, Ono A, et al. Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis. Hepatol Res 2007; 37:615-619. (Pubitemid 47009247)
32. Fukushima H, Miwa Y, Shiraki M, et al. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res 2007; 37:765-770. (Pubitemid 47054783)
33. Kobayashi M, Ikeda K, Arase Y, et al. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus. J Gastroenterol 2008; 43:63-70. (Pubitemid 351324988)
34. Takeshita S, Ichikawa T, Nakao K, et al. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutr Res 2009; 29:89-93.
35. Ishikawa T, Michitaka I, Kamimura H, et al. Oral branched-chain amino acids administration improves impaired liver dysfunction after radiofrequency ablation therapy for hepatocellular carcinoma. Hepatogastroenterology 2009; 56:1491-1495.
36. Okabayashi T, Nishimori I, Sugimoto T, et al. Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. J Gastroenterol Hepatol 2008; 23:1869-1873.